Meinian Onehealth Hits Day Low of CNY 5.76 Amid Price Pressure

Meinian Onehealth Healthcare Holdings Co., Ltd. experienced a notable decline today, with the stock dropping by 3.67% on March 20, 2026. The stock reached an intraday low of CNY 5.76, reflecting a challenging trading session. Over the past week, the stock has seen a decrease of 9.97%, and its performance over the last month has been even more pronounced, with a decline of 16.95%. In terms of annual performance, Meinian Onehealth has faced a downturn of 9.69%, contrasting sharply with the China Shanghai Composite, which has gained 16.08% over the same period. The company's market capitalization stands at CNY 26,659 million, categorizing it as a large-cap entity within the Pharmaceuticals & Biotechnology industry. Despite a significant growth in net profit of 406.2% reported in September, the company has struggled with a return on equity of 4.95% and a high price-to-book ratio of 3.37. The current dividend yield is noted at 0.20%, indicating a cautious approach to shareholder returns amidst fluctuating performance metrics.